{"filings":[{"id":471276,"accession_number":"0001099219-26-000037","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2026-05-15T20:18:47+00:00","items":["8.01","9.01"],"status":"ready","headline":"MetLife declares Q2 2026 preferred stock dividends on Series A, E, F","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Series A floating rate preferred: $0.31190376 per share, payable June 15, 2026.","Series E 5.625% preferred: $351.5625 per share ($0.3515625 per depositary share).","Series F 4.75% preferred: $296.875 per share ($0.296875 per depositary share).","Record date set for May 29, 2026 due to May 31 falling on a Sunday."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91295,"accession_number":"0001099219-26-000032","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"MetLife Q1 2026 net income rises 30% to $1.1B, adjusted EPS up 23% to $2.42","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Adjusted earnings up 18% to $1.6B driven by higher variable investment income and volume growth.","Asia segment adjusted earnings up 31% to $487M; Group Benefits up 19% to $439M.","Returned over $1.1B to shareholders via share repurchases ($750M) and dividends ($370M).","Total assets under management reached $736.3B as of March 31, 2026.","Direct expense ratio improved to 11.9%, ahead of 12.1% annual target."],"consensus_eps_estimate":null,"consensus_eps_actual":1.74,"consensus_revenue_estimate":null,"consensus_revenue_actual":19074000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91294,"accession_number":"0001099219-26-000019","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2026-04-07T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"MetLife estimates Q1 2026 variable investment income $475M-$525M pre-tax; full-year guidance ~$1.6B","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Estimates Q1 2026 variable investment income of $475M to $525M pre-tax (unaudited, preliminary).","Full-year 2026 variable investment income guidance remains ~$1.6B pre-tax, implying ~$400M per quarter average.","Variable investment income includes private equity, real estate and other funds and prepayment fees.","Full Q1 2026 earnings release scheduled for May 6, 2026; results may differ materially from preliminary estimate."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101283,"accession_number":"0001099219-26-000015","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2026-03-05T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"MetLife confirms Q1 2026 Series A preferred dividend of $0.31501229/share","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Preferred Series A dividend of $0.31501229 per share payable March 16, 2026.","Record date set for Feb. 27, 2026 due to Sunday March 1; NYSE to set ex-dividend date.","Confirms previously announced declaration; dividend rate unchanged on $25 liquidation preference."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101282,"accession_number":"0001193125-26-076647","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2026-02-26T23:59:59+00:00","items":["2.03","8.01","9.01"],"status":"ready","headline":"MetLife issues $1B of 5.850% subordinated debentures due 2056","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $1B aggregate principal of 5.850% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2056.","Debentures priced Feb 24, 2026, and issued Feb 26, 2026; subordinated unsecured obligation.","Underwriters include Barclays, BofA, Citi, Goldman Sachs, Morgan Stanley, and Wells Fargo.","Issued under shelf registration statement on Form S-3 (File No. 333-287370)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101281,"accession_number":"0001193125-26-067070","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"MetLife expands board to 13, elects Daniel S. Glaser and Michelle R. Seitz as independent directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board increased from 11 to 13; Glaser and Seitz elected as independent directors effective Feb 24, 2026.","Glaser appointed to Audit, Compensation, and Finance & Risk Committees; Seitz to Compensation, Governance, and Investment Committees.","Standard non-management director compensation: $355,000 annual retainer ($205k stock, $150k cash), pro-rated for partial year."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101280,"accession_number":"0001099219-26-000010","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2026-02-17T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"MetLife declares Q1 2026 preferred dividends; Series A subject to confirmation","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Semi-annual dividend of $29.375/sh on Series D (5.875% fixed-to-floating, $1,000 liq. pref.).","Quarterly dividend of $351.5625/sh on Series E (5.625%, $25,000 liq. pref.); depositary shares $0.3515625 each.","Quarterly dividend of $296.875/sh on Series F (4.75%, $25,000 liq. pref.); depositary shares $0.296875 each.","Series A floating rate dividend of $0.31501229/sh ($25 liq. pref.) subject to financial test confirmation expected March 5, 2026.","All dividends payable March 16, 2026 to holders of record as of Feb. 27, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101279,"accession_number":"0001099219-26-000008","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2026-02-04T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"MetLife reports 10% adjusted EPS growth in FY2025; Q4 adj. EPS $2.58 beats; returns $4.4B to shareholders","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2025 net income $3.2B ($4.71/sh); adjusted EPS ex notable items $8.89, up 10% YoY.","PFOs $57.6B (+10%); record RIS PRT $14.2B and UK longevity reinsurance $11.1B.","Direct expense ratio 11.7% beat 12.1% target; FCF ratio 81% exceeded 65-75% target; adj. ROE 16%.","Q4 adj. earnings $1.648B (+13%); adj. EPS ex notable $2.58 (+24%); driven by higher VII and volume.","2026 outlook: double-digit EPS growth, adj. ROE 15-17%, direct expense target 12.1%, VII ~$1.6B."],"consensus_eps_estimate":null,"consensus_eps_actual":4.71,"consensus_revenue_estimate":null,"consensus_revenue_actual":77084000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101278,"accession_number":"0001099219-26-000005","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2026-01-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"MetLife reorganizes segments: MIM becomes reportable, MetLife Holdings moved to Corporate & Other","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Effective Q4 2025: MetLife Investment Management becomes a separate reportable segment, formerly in Corporate & Other.","MetLife Holdings no longer a reportable segment; moved to Corporate & Other, with products recast to Group Benefits and RIS.","Changes applied retrospectively for quarters Dec 31, 2024 through Sep 30, 2025; no impact on prior consolidated net income.","Amended fee agreements between MIM and MetLife entities effective Jan 1, 2025 at current market rates, applied retrospectively for Q1-Q3 2025.","New Quarterly Financial Supplement format adopted for Q4 and full year 2025 to reflect revised segments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117643,"accession_number":"0001099219-25-000241","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-12-30T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"MetLife closes PineBridge acquisition; combined AUM reaches $734.7B","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Closed acquisition of PineBridge Investments on December 30, 2025, announced in December 2024.","Combined AUM of $734.7B as of September 30, 2025 pro forma; 55% in public fixed income.","Acquisition excludes PineBridge's private equity funds group and China joint venture.","Brian Funk named president of combined MIM; John McCallion remains CFO and Head of MIM.","More than half of acquired client assets are outside the U.S., with one-third in Asia."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117642,"accession_number":"0001099219-25-000239","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-12-22T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"MetLife provides preliminary Q4 2025 variable investment income and 2026 outlook; $2.85B share repurchases","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Q4 2025 variable investment income estimated $385M–$435M pre-tax vs $425M target; FY 2025 private equity return ~7.7%.","2026 outlook assumes 9% PE return; total variable investment income ~$1.6B pre-tax; asset balances expected to decrease over 1–3 years.","Capital deployment: $4B organic, $1B M&A (incl. PineBridge closing); total stock repurchases ~$2.85B in 2025 ($430M in Q4).","Anticipates a similar level of common stock repurchases in 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117641,"accession_number":"0001099219-25-000234","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-12-01T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"MetLife completes $10B variable annuity risk transfer with Talcott Resolution","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Transaction reinsures ~$10B of U.S. retail variable annuity and rider reserves with Talcott Resolution.","Expected foregone annual adjusted earnings ~$100M, partially offset by ~$45M annual hedge cost savings.","MetLife Investment Management to manage ~$6B of assets under agreements with Talcott.","Reduces portfolio risk and accelerates run-off of legacy blocks in MetLife Holdings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117640,"accession_number":"0001099219-25-000232","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-11-17T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"MetLife declares Q4 2025 preferred stock dividends on Series A, E, F","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Series A (MET PRA): $0.33489390 per share, payable Dec. 15 to holders of record Nov. 28.","Series E (MET PRE): $351.5625 per share ($0.3515625 per depositary share), payable Dec. 15.","Series F (MET PRF): $296.875 per share ($0.296875 per depositary share), payable Dec. 15."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117639,"accession_number":"0001099219-25-000227","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"MetLife Q3 adj EPS $2.34 (+21% YoY); secured $12B PRT mandates in Q4-to-date","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Adjusted earnings $1.6B ($2.37/diluted share); adjusted EPS ex-notable items $2.34 (+21% YoY).","Premiums, fees & other revenues $12.5B; net investment income up 16% to $6.1B.","Variable investment income $483M on higher private equity returns; VII quarterly guidance exceeded.","Returned ~$875M to shareholders via buybacks ($500M) and dividends ($375M) in Q3.","Asia sales up 34% constant currency; direct expense ratio of 11.6% below 12.1% annual target."],"consensus_eps_estimate":null,"consensus_eps_actual":3.54,"consensus_revenue_estimate":null,"consensus_revenue_actual":53270000000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117638,"accession_number":"0001099219-25-000224","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-10-14T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"MetLife eliminates Series G Preferred Stock designation after full redemption","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Filed Certificate of Elimination with Delaware on October 14, 2025 to remove Series G Preferred Stock from charter.","All Series G shares had been previously redeemed, repurchased, or reacquired by the Company.","Eliminated shares return to status of authorized but unissued preferred stock, without series designation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134077,"accession_number":"0001099219-25-000222","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-09-22T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"MetLife: Q3 2025 variable investment income on track to meet $425M target","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 2025 variable investment income estimated at ~$425M pre-tax, consistent with full-year ~$1.7B guidance.","Includes private equity, real estate, other funds, and prepayment fees.","Quarterly earnings release scheduled for November 5, 2025.","Preliminary estimate; actual results may differ materially."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134076,"accession_number":"0001099219-25-000219","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-09-15T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"MetLife warns shareholders to reject unsolicited mini-tender offer at 34% below market","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Potemkin offers $53.00/share for up to 10,000 MET shares, 34.42% below $80.82 closing price on Sept 12, 2025.","Offer covers only 0.00002% of outstanding shares; MetLife does not endorse and recommends shareholders reject.","Mini-tender offers avoid many SEC disclosure requirements; SEC has warned investors of below-market bids.","Shareholders who already tendered may withdraw before offer expires Oct 7, 2025 at 5 p.m. ET."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134075,"accession_number":"0001193125-25-194038","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-09-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"MetLife redeems all Series G Preferred Stock on Sept 15, 2025 at $1,000/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Redemption of all outstanding 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G.","Redemption date: September 15, 2025; price: $1,000 per share plus separate final dividend.","Final semi-annual dividend of $19.250 per share payable Sept 15 to holders of record Aug 29.","Redemption agent: Computershare Trust Company, N.A.; shares held through DTC.","Dividends will cease accruing after the redemption date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134074,"accession_number":"0001099219-25-000201","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-08-15T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"MetLife declares Q3 2025 preferred dividends on five series","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Quarterly dividend of $0.35263005/sh on Series A floating-rate preferred (MET PRA).","Semi-annual dividend of $29.375/sh on Series D 5.875% preferred.","Quarterly dividends: Series E (MET PRE) $0.3515625/depositary sh; Series F (MET PRF) $0.296875/depositary sh.","Semi-annual dividend of $19.250/sh on Series G 3.850% fixed-rate reset preferred.","All dividends payable Sept. 15, 2025 to holders of record Aug. 29, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134073,"accession_number":"0001099219-25-000191","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"MetLife Q2 adjusted EPS $2.02, down 11% YoY; net income $698M; PFOs ex-PRT up 5%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Adjusted earnings $1.36B ($2.02 EPS) vs $1.63B ($2.28) in 2Q24, down 16% (11% per share).","Net income $698M ($1.03 EPS) vs $912M ($1.28) in prior year, down 23%.","Adjusted PFOs ex-PRT rose 5% to $12.4B; net investment income +9% to $5.7B; variable investment income fell to $195M pre-tax.","Returned ~$900M to shareholders: $510M buybacks + $382M dividends; holding company cash $5.2B.","Asia sales +9% CC, Latin America adj earnings +15% CC, EMEA +30%; Group Benefits adj PFOs +4%."],"consensus_eps_estimate":null,"consensus_eps_actual":2.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":35909000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134072,"accession_number":"0001193125-25-169311","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-07-30T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"MetLife appoints Adrienne O'Neill as EVP and CAO, effective Sept 2, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["O'Neill joins from Manulife; most recently CFO of Asia Segment.","Base salary $525,000; sign-on stock awards with aggregate grant value of $1.95M.","Replaces interim CAO Toby Srihiran Brown, who returns to EVP Global Head of Reinsurance.","O'Neill will lead corporate accounting, reporting, and financial planning."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134071,"accession_number":"0001193125-25-154039","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-07-01T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"MetLife co-sponsors Chariot Re; transfers ~$10B in annuity liabilities to new reinsurer","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Chariot Re, co-sponsored by MetLife and General Atlantic, will reinsure ~$10B of MetLife's structured settlement and pension risk transfer annuity contracts.","Chubb is lead investor; MetLife Investment Management and General Atlantic serve as exclusive external asset managers for Chariot Re.","Cynthia Smith, former MetLife executive, named CEO of Chariot Re.","MetLife will continue to handle all customer-related functions; policyholder commitments unchanged."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150826,"accession_number":"0001099219-25-000186","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-06-23T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"MetLife estimates Q2 2025 variable investment income between $175M and $225M pre-tax","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Q2 2025 variable investment income estimated at $175M-$225M pre-tax, including private equity and real estate.","Full Q2 2025 earnings release scheduled for August 6, 2025.","Estimate is preliminary and unaudited; actual results may differ materially.","Variable investment income includes private equity, real estate, other funds, and prepayment fees."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150825,"accession_number":"0001099219-25-000174","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-06-20T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"MetLife shareholders elect 11 directors, ratify auditor, approve executive pay at 2025 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 11 director nominees elected; top vote-getter Christian Mumenthaler (555.3M for), lowest Denise Morrison (522.7M for).","Ratification of Deloitte & Touche as 2025 auditor: 558.7M for, 38.9M against, 0.5M abstain.","Advisory say-on-pay approved: 528.3M for, 26.3M against, 1.9M abstain; broker non-votes 41.7M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150824,"accession_number":"0001193125-25-142086","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-06-17T23:59:59+00:00","items":["2.03"],"status":"ready","headline":"MetLife issues ¥87.84B in senior notes across six tranches due 2032-2055","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued ¥87.84B aggregate principal of yen-denominated senior notes with coupons from 2.14% to 3.62%.","Series include ¥10B at 2.14% due 2032; ¥15B at 2.46% due 2035; ¥10.7B at 2.59% due 2037.","Also ¥12.14B at 2.83% due 2040; ¥23.6B at 3.29% due 2045; ¥16.4B at 3.62% due 2055.","Interest payable semiannually on June 17 and December 17, starting December 17, 2025.","Proceeds to refinance ¥25.2B of 0.495% senior notes due 2026 and for general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150823,"accession_number":"0001099219-25-000139","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-05-15T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"MetLife declares Q2 2025 preferred stock dividends payable June 16","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Series A floating rate preferred: $0.35141735 per share.","Series E 5.625% preferred: $351.5625 per share ($0.3515625 per depositary share).","Series F 4.75% preferred: $296.875 per share ($0.296875 per depositary share).","Dividends payable June 16, 2025 to holders of record May 30, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150822,"accession_number":"0001193125-25-107504","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-04-30T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"MetLife to reinsure ~$10B in variable annuity reserves with Talcott; reduces tail risk 40%","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reinsurance agreement with Talcott covers ~$10B of U.S. retail variable annuity and rider reserves.","Combined transaction value ~$250M from ceding commission and capital released over time.","Foregone annual adjusted earnings ~$100M, offset by ~$45M annual hedge cost savings.","Account values reduced by ~40%, lowering retail variable annuity tail risk significantly.","MetLife Investment Management will manage ~$6B of assets under mandates with Talcott."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150821,"accession_number":"0001099219-25-000133","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-04-30T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"MetLife Q1 net income up 10% to $879M; adjusted EPS $1.96 beats; new $3B buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $879M ($1.28/diluted EPS), up 10% YoY; adjusted earnings $1.349B ($1.96/diluted), up 1% YoY.","Premiums, fees and other revenues up 14% to $13.6B; Group Benefits adjusted earnings +29% to $367M.","Board authorized new $3.0B share repurchase program; returned $1.8B in Q1 via buybacks and dividends.","Agreed to reinsure ~$10B of U.S. retail VA reserves with Talcott; expected close H2 2025, ~$250M value.","Adjusted book value per share up 4% to $55.01; direct expense ratio 12.0% below 12.1% annual target."],"consensus_eps_estimate":null,"consensus_eps_actual":1.28,"consensus_revenue_estimate":null,"consensus_revenue_actual":18569000000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169766,"accession_number":"0001193125-25-067184","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-03-28T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"MetLife director David L. Herzog resigns from board effective May 1, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["David L. Herzog notified the Board of his resignation on March 27, 2025.","Resignation effective May 1, 2025; he will not stand for re-election at 2025 annual meeting.","Herzog's departure is not due to any disagreement with the company on operations or policies.","No replacement director announced; board size will decrease by one."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169765,"accession_number":"0001193125-25-053957","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-03-13T23:59:59+00:00","items":["2.03","8.01","9.01"],"status":"ready","headline":"MetLife issues $1B of 6.350% subordinated debentures due 2055","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $1.0B aggregate principal of 6.350% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2055.","Debentures issued under Thirteenth Supplemental Indenture dated March 13, 2025, with Bank of New York Mellon as trustee.","Underwriters include BNP Paribas, BofA Securities, Deutsche Bank, J.P. Morgan, Morgan Stanley, and TD Securities.","Replacement Capital Covenants terminated with consent of debenture holders; prior covered debt (5.70% Senior Notes due 2035) replaced.","Debentures are subordinated and rank junior to MetLife's senior debt; proceeds for general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169764,"accession_number":"0001099219-25-000077","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-03-05T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"MetLife confirms Series A preferred dividend for Q1 2025","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Series A preferred dividend confirmed at $0.35516415 per share for Q1 2025.","Payable March 17, 2025 to holders of record as of Feb. 28, 2025.","NYSE will set ex-dividend date following this confirmatory notice.","Dividend rate unchanged from prior quarter; no material new information."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169763,"accession_number":"0001193125-25-045644","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-03-04T23:59:59+00:00","items":["2.03"],"status":"ready","headline":"MetLife establishes $1.25B P-Caps facility with 5.740% Senior Notes due 2055","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Trust issued 1.25M P-Caps for aggregate $1.25B; proceeds invested in U.S. Treasury strips.","MetLife has 30-year right to issue 5.740% Senior Notes due 2055 to Trust in exchange for Eligible Assets.","Semi-annual facility fee of 1.2373% p.a. on unexercised portion of Issuance Right.","Issuance Right triggers: consolidated net worth (excl. AOCI) below $10B or bankruptcy events.","Senior Notes redeemable at MetLife's option; Trust will redeem P-Caps upon redemption or maturity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169762,"accession_number":"0001193125-25-039258","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"MetLife appoints interim CAO and adds Christian Mumenthaler to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Toby Srihiran Brown appointed interim Chief Accounting Officer, effective March 15, 2025, replacing departing Tamara L. Schock.","Brown is EVP and Global Head of Reinsurance since Oct 2024; previously Global Chief Auditor (2020-2024) and multiple CFO roles.","Christian Mumenthaler elected to board, effective May 1, 2025, increasing board size to 14; deemed independent director.","Mumenthaler will serve on Finance & Risk and Investment Committees; receives standard non-management director retainer of $325,000/year."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169761,"accession_number":"0001099219-25-000041","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-02-18T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"MetLife declares Q1 2025 preferred dividends; Series A subject to financial test confirmation","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Series D semi-annual $29.375/share; Series E quarterly $0.3515625/depositary share; Series F quarterly $0.296875/depositary share; Series G semi-annual $19.250/share.","Series A quarterly $0.35516415/share, payable subject to confirmation of meeting financial tests; confirmation expected on/about March 5, 2025.","Dividends payable March 17, 2025 to holders of record as of Feb. 28, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169760,"accession_number":"0001099219-25-000039","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-02-05T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"MetLife FY2024 net income $4.2B, EPS up 228%; raises adjusted ROE target to 15-17%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2024 net income of $4.2B ($5.94 EPS) vs $1.4B ($1.81) in 2023; adjusted EPS $8.15, up 12%.","Q4 net income $1.2B ($1.78 EPS); adjusted EPS $2.09, up 14% YoY.","Adjusted book value per share $54.81, up 2%; holding company cash $5.1B above $3-4B target.","New near-term targets: adjusted ROE 15-17% (from 13-15%), double-digit adjusted EPS growth, direct expense ratio 12.1%.","2025 guidance: VII ~$1.7B, tax rate 24-26%; expects $25B free cash flow over next five years."],"consensus_eps_estimate":null,"consensus_eps_actual":5.94,"consensus_revenue_estimate":null,"consensus_revenue_actual":70986000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169759,"accession_number":"0001193125-25-004464","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2025-01-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"MetLife CAO Tamara L. Schock resigns; last day March 14, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Executive VP and Chief Accounting Officer Tamara L. Schock resigns to pursue another opportunity.","Last day of employment expected on or about March 14, 2025.","Resignation not due to any disagreement with MetLife's financial reporting or operations.","No replacement named in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186817,"accession_number":"0001099219-24-000264","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2024-12-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"MetLife unveils New Frontier strategy targeting double-digit EPS growth, 15-17% ROE","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["New five-year strategy aims for double-digit adjusted EPS growth (from ~6%) and 15-17% adjusted ROE (from 12-14%).","Free cash flow target raised to $25B+ from ~$20B; direct expense ratio target reduced by 100 bps from 12.3%.","Growth priorities: extend Group Benefits leadership, expand retirement platform, accelerate asset management, grow in high-opportunity international markets.","CEO Michel Khalaf says MetLife is positioned to deliver growth and attractive returns with lower risk.","Commitments build on Next Horizon strategy that previously beat all targets, including $22B returned to shareholders since 2020."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186816,"accession_number":"0001193125-24-274879","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2024-12-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"MetLife and General Atlantic form Chariot Re; MetLife to cede ~$10B in annuity reserves","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["MetLife and General Atlantic each take ~15% equity in new Bermuda reinsurer Chariot Re; initial combined equity >$1B; Chubb as anchor third-party investor.","MetLife to initially cede ~$10B in statutory reserves from structured settlements and pension risk transfer group annuities.","MetLife expects ~$1B increase in available capital; transaction targeted to close in H1 2025 subject to regulatory approvals.","Chariot Re CEO will be Cynthia Smith (30-year MetLife veteran); Board includes MetLife's Toby Srihiran Brown and GA's Graves Tompkins.","Asset management will be exclusively by MetLife Investment Management and General Atlantic."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186815,"accession_number":"0001099219-24-000260","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2024-11-15T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"MetLife declares Q4 2024 preferred dividends on Series A, E, F","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Series A: $0.39232690 per share; Series E: $351.5625 per share ($0.3515625 per depositary share); Series F: $296.875 per share ($0.296875 per depositary share).","Dividends payable Dec. 16, 2024 to shareholders of record as of Nov. 29, 2024.","Series A trades as MET PRA, Series E as MET PRE, Series F as MET PRF on NYSE."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186814,"accession_number":"0001099219-24-000255","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"MetLife Q3 adjusted EPS $1.95, down 1% YoY; net income surges to $1.3B on derivative gains","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $1.275B ($1.81 per share) vs $422M ($0.56) in Q3'23, up 202% on higher net derivative gains.","Adjusted earnings $1.375B ($1.95 per share) vs $1.488B ($1.97) in Q3'23, down 8% (1% per share) on lower variable investment income.","Variable investment income fell to $128M post-tax from $141M in Q3'23, below $375M quarterly target range.","Book value $39.02 per share up 33% YoY; book value ex-AOCI other than FCTA $54.72, up 3%.","Holding company cash $4.5B above $3-4B target; share repurchases ~$0.8B in Q3, with ~$130M shares bought in Oct 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":4.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":52320000000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203352,"accession_number":"0001193125-24-229033","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2024-09-30T23:59:59+00:00","items":["2.03","8.01","9.01"],"status":"ready","headline":"MetLife issues additional $250M 5.300% Senior Notes due 2034","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $250M additional aggregate principal of 5.300% Senior Notes due 2034 on Sept 30, 2024.","Notes are additional to $500M previously issued under same terms, totaling $750M outstanding.","Interest rate 5.300%, maturity 2034; issued under shelf registration statement.","Underwriters include Morgan Stanley, BofA Securities, and Wells Fargo Securities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203351,"accession_number":"0001099219-24-000210","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2024-08-15T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"MetLife declares Q3 2024 preferred stock dividends on five series, payable Sept 16","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Series A quarterly dividend $0.41713578 per share; Series D semi-annual $29.375 per share.","Series E quarterly $351.5625 per share ($0.3515625 per depositary share); Series F quarterly $296.875 per share ($0.296875 per depositary share).","Series G semi-annual dividend $19.250 per share.","All dividends payable Sept. 16, 2024 to holders of record Aug. 30, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203350,"accession_number":"0001099219-24-000196","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2024-07-31T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"MetLife Q2 net income $912M ($1.28 EPS); adj EPS $2.28 beats $1.94; $0.9B buyback in Q2","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $912M ($1.28) vs $370M ($0.48) YoY; adjusted earnings $1.628B ($2.28) vs $1.492B ($1.94).","Group Benefits adjusted earnings $533M (+43% YoY) driven by strong underwriting margins.","Returned $0.9B to shareholders via buybacks in Q2; ~$270M additional in July 2024.","Holding company cash $4.4B above $3.0-4.0B target; direct expense ratio 11.9% below 12.3% target.","Variable investment income $298M pre-tax (vs $221M YoY), driven by higher private equity returns."],"consensus_eps_estimate":null,"consensus_eps_actual":2.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":33880000000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219727,"accession_number":"0001099219-24-000193","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2024-06-24T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Shareholders approve MetLife 2025 Stock Plan, AVIP; all director nominees elected","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Shareholders elected 13 directors: highest vote 603M for Laura Hay, lowest 575M for Cheryl Grise.","Ratified Deloitte as auditor for 2024: 615.9M for, 32.3M against.","Advisory say-on-pay passed: 571.8M for, 31.6M against.","2025 Stock and Incentive Compensation Plan approved: 582.3M for, 21.7M against.","Shareholder proposal for racial equity audit rejected: 99.4M for, 501.5M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219726,"accession_number":"0001193125-24-155141","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2024-06-05T23:59:59+00:00","items":["2.03","8.01","9.01"],"status":"ready","headline":"MetLife issues $500M of 5.300% Senior Notes due 2034","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$500M aggregate principal, 5.300% fixed rate, maturing 2034, issued June 5, 2024.","Issued under shelf registration; underwriters include Citigroup, Deutsche Bank, Goldman Sachs, HSBC, Wells Fargo.","Proceeds expected for general corporate purposes per typical debt issuance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219725,"accession_number":"0001099219-24-000144","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2024-05-15T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"MetLife declares Q2 2024 preferred stock dividends for Series A, E, F","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Series A floating rate preferred: $0.43023800 per share, payable June 17, 2024.","Series E 5.625% preferred: $351.5625 per share ($0.3515625 per depositary share).","Series F 4.75% preferred: $296.875 per share ($0.296875 per depositary share).","All dividends payable June 17, 2024 to shareholders of record as of May 31, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219724,"accession_number":"0001099219-24-000139","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2024-05-01T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"MetLife Q1 net income $800M ($1.10 EPS), adj EPS $1.83; board approves $3B buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $800M ($1.10 per share) vs $14M ($0.02) in Q1 2023; adjusted earnings $1.3B ($1.83 per share), up 20% YoY.","Premiums, fees and other revenues $11.975B, up 4% YoY; total revenues $16.057B.","Board approved new $3B share repurchase authorization; $1.2B repurchased in Q1 2024 plus ~$330M in April.","Book value per share $34.54; adjusted ROE excluding AOCI other than FCTA of 13.8%.","Holding company cash $5.2B, above target buffer of $3.0-$4.0B."],"consensus_eps_estimate":null,"consensus_eps_actual":1.1,"consensus_revenue_estimate":null,"consensus_revenue_actual":16057000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239508,"accession_number":"0001193125-24-065398","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2024-03-12T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"MetLife to redeem all £350M of 5.375% Senior Notes due Dec 2024 on Apr 11","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Full redemption of £350 million outstanding principal of 5.375% Senior Notes due December 9, 2024.","Redemption date is April 11, 2024; interest ceases after that date.","Redemption price based on yield of 5% UK gilt due March 2025 plus accrued interest.","Notes held through Clearstream and Euroclear; payment via Bank of New York Mellon."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239507,"accession_number":"0001193125-24-062174","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2024-03-07T23:59:59+00:00","items":["2.03","8.01","9.01"],"status":"ready","headline":"MetLife issues ¥112.3B in seven tranches of senior notes with coupons ranging 1.009%-2.448%","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued ¥7.1B of 1.009% Senior Notes due 2029, ¥23.1B of 1.415% due 2031, and five other tranches through 2059.","Total aggregate principal amount ¥112.3B across seven yen-denominated tranches.","Notes sold via underwriters Mizuho, Morgan Stanley, SMBC Nikko, and Merrill Lynch.","Issuance under shelf registration statement (File No. 333-268442) and prospectus supplement dated March 1, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239506,"accession_number":"0001099219-24-000067","cik":1099219,"company_name":"METLIFE INC","ticker":"MET","form_type":"8-K","filed_at":"2024-03-05T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"MetLife confirms Q1 2024 Series A preferred stock dividend of $0.42000544 per share","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Dividend of $0.42000544 per share on floating rate non-cumulative preferred stock, Series A (MET PRA).","Payable March 15, 2024, to shareholders of record as of Feb. 29, 2024.","NYSE will set ex-dividend date following this confirmatory announcement.","Dividend was previously announced; this release confirms it."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":53533936904.08551,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2024-03-05T23:59:59+00:00|239506"}